Clinical trial
Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
NCT00128401 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00128401 |
|---|---|
| Title | Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia |
| Official title | Effect of D-Cycloserine on Treatment of Social Phobia |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Phobic Disorders, Anxiety, Social Phobia |
| Intervention type | Drug |
| Interventions | D-Cycloserine, Placebo |
| Enrollment | 48 |
| Start date | Aug 1, 2005 |
| Primary completion | Jun 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Aug 9, 2005 |
| Last update posted | May 20, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: